Ignite Creation Date:
2025-12-25 @ 12:08 AM
Ignite Modification Date:
2025-12-31 @ 10:10 PM
Study NCT ID:
NCT02126358
Status:
COMPLETED
Last Update Posted:
2016-10-18
First Post:
2014-03-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Gemigliptin-Rosuvastatin Fix-dose Combination Phase 3(BALANCE)
Sponsor:
LG Life Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-05
Start Date Type:
None
Primary Completion Date:
2016-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-03
Completion Date Type:
ACTUAL
First Submit Date:
2014-03-04
First Submit QC Date:
None
Study First Post Date:
2014-04-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-10-17
Last Update Post Date:
2016-10-18
Last Update Post Date Type:
ESTIMATED